22 May 2013
Keywords: argenta, zafgen, obesity, drug, discovery, accord, uk
Article | 09 February 2009
The UK's Argenta Discovery, the contract research and respiratory R&D company, and Zafgen, a private, venture-backed US biopharmaceutical
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 February 2009
21 May 2013
© 2013 thepharmaletter.com